Remove brand-insights
article thumbnail

Enhancing pharma brand performance through in-depth customer engagement insights

pharmaphorum

Enhancing pharma brand performance through in-depth customer engagement insights Mike.Hammerton Mon, 02/10/2023 - 08:00 Bookmark this

118
118
article thumbnail

How Real-Time Insights Help Pharma Brands Track Post-Conference Learnings

InCrowd

The post How Real-Time Insights Help Pharma Brands Track Post-Conference Learnings appeared first on InCrowd. The company sought to: Explore which tumor type/track had the most exciting data presented at ESMO 2022. Understand what attendees found exciting about the tumor type data presented. See the results in our new case study.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Hubs East 2024: Leveraging Digital Hubs

Pharmaceutical Commerce

Presentation offers insight on this aforementioned model that assists retail and specialty-lite brands.

103
103
article thumbnail

Intelligence Node partners with Kroger Marketplace

Drug Store News

The two brands will work together to provide clearer, more informative product listings to improve the customer experience as well as better insights into product performance.

104
104
article thumbnail

Paul K Owens, VP of Global Brand Development, Insulins & Glucagon at Eli Lilly & Company Shares Insights from the US FDA Approval of Lyumjev

PharmaShots

Owens is the Global Brand Development Leader, Insulins, Glucagon & Devices at Eli Lilly & Company. In his current role within Lilly Diabetes, he has primary responsibilities for the global development of new insulin assets, in addition to lifecycle management for all Lilly insulin and Lilly glucagon brands.

FDA 40
article thumbnail

STAT+: What Eli Lilly’s Zepbound reveals about the intricate process of naming drugs today

STAT

Whether you’re a fan of the drug name Zepbound or, like one X user , think it sounds like “an off brand bus line,” you’re likely to have some opinion about the new moniker for Eli Lilly’s blockbuster diabetes drug Mounjaro. The company announced the new name on Nov.

128
128
article thumbnail

Rising prices push consumers to purchase store-brand products

Drug Store News

According to a survey by Reach 3 Insights, 80% of Americans say that rising prices have driven them to purchase more store-brand products.

109
109